Nuformix plc (LON:NFX)
0.2990
+0.0040 (1.36%)
At close: Jan 22, 2026
Nuformix Market Cap
Nuformix has a market cap or net worth of 6.31 million as of January 22, 2026. Its market cap has increased by 835.69% in one year.
Market Cap
6.31M
Enterprise Value
6.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 6.31M, a decrease of -63.49%. That is a compound annual growth rate of -11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.22M | 15.69% |
| Dec 31, 2025 | 5.38M | 698.00% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.41B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |